Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. PIXUVRI (pixantrone (dimaléate de))
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PIXUVRI (pixantrone (dimaléate de))

Medicine - Posted on Jan 13 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • pixantrone (dimaléate de)
history (2)
  • 11/9/16

    PIXUVRI (pixantrone), anthracycline and related
    Actual benefit low in monotherapy for aggressive non-Hodgkin B-cell lymphoma in 3rd or 4th line Since 2012, PIXUVRI has had ...
    CAV :
    54321
    icône flèche
  • 7/10/13

    PIXUVRI (pixantrone), anthracycline et apparentés
    Pas d’avantage clinique démontré dans le lymphome non hodgkinien agressif à cellules B PIXUVRI a l’AMM en monothérapie chez ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L01DB11
Manufacturer
SERVIER
Presentation

PIXUVRI 29 mg, poudre pour solution à diluer pour perfusion (code CIS : 69454261)
Boîte de 1 flacon - Code CIP : 34009 583 972 4 0

All our publications
    Drug therapy Hematologic cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
eNq9WF1v2jAUfedXRHlPQko/2BSoNtZuSK3G2qJNe0EmuRSzYKfXNh/79XMI1dLJUVdT9wnFNude+9x7fOTkfLPMvRWgoJz1/Dhs+x6wlGeU3ff88d1l0PXP+61kQVakvqwbtidxN/a9NCdC9PxyPpwCYSL8cX31CTQCoN9veQmfLiCVT9YpSfPwCxHza1KUa7xkxWnmLUHOedbzCyV3o14iJOo8+muOv0RBUkii/Uh9djE5ro8nUQn2H6hKAF4Rdm8EBWaFmSpEYHJAJNxz3Dbk27HCpuIGBFeYwojI+Qj5imaQGUPMSC7AKshsnd0CrnKQZRAjeLRIl8IKnCzI5gYehuakP+jZgdzIoB3EZ+347OQs7pyeHtuRi7WjMrOgNxEVBWaTo3fdTrdzFAGLCrpRK6SB/iVMImcQZHRJctB8BhlY0jbiKEnuiDAqBk9rzlEchIdnCyOjosjJNlyIwvaoCBI9DaiVwd1Gyh3codaqXJ/ZP/hM5Xn0wqzHeyVxlHEpVAOudEGaBWV8a3sQA84kbJoZtdNAudnXIgXxerC/dTca0UZqmtPUVu20HikQcnwzbBa7N9KJj0TAGN0JxXfKMr4Wry9AdcIdZV/sNNQIqrmJS3JO45MT6/76qTlsuJcuFPICIi1NVByiOEM244dqjS5YM9Rjub5Fpe6ME081SIN1mlgqki7RR6fnrAncNVg1YQT9fHFnWznfFOD2dvdphKZZr865nWK7uAZ0qTbm/vLCr/rfia9WaNaVuZSFeB9F6/U6nBMRCN1AEM7wLa+E2gXtzvA7cQGVK6pk1VHq0+q+fBl5tn34nE841Pvu/7/32MYYEhUcwEUl2c6EdXjx+lr91/g6S3v0RFjchdmZVCIpZ64ckpqa7dGht4Omll1qQZNfZzPa8AbTWJpJVL3/9FtJVL799Ft/APK1E1o=
ThpFe6h2CPgsTdSG